The notion of potential existence of gene environment interaction (GxE) in Alzheimer's disease (AD) has substantial impact on understanding the role of genetic and non-genetic contribution to this disorder. Keeping in mind this background we examined the genetic and environmental factors which may determine their relative contribution to AD. Based on well defined inclusion and exclusion criteria this study includes 70 AD patients and 75 age-matched controls. Organochlorine Pesticides (OCPs) were analyzed in blood by using gas chromatography and serum metals were analyzed by using an autoanalyser. The LRPAP1 and APOE gene polymorphism were determined by polymerase chain reaction and restriction fragment length polymorphism respectively. The frequency of APOE ε4 allele and LRPAP1 I allele were significantly high (p=0.000 for both allele) in AD patients as compared to controls. The significantly high levels of β-hexachlorocyclohexane (β-HCH) and dieldrin are risk factors for AD independent of the genetic risk factor, recording an odds ratio of 2.777 and 2.344 respectively. This study suggests that out of the environmental factors, high β-HCH levels were the best predictor of presence of AD independent of the genetic component and low levels of serum iron play a protective role against AD.
Introduction
Alzheimer's disease (AD) is defined as a progressive and fatal neurodegenerative disorder manifested by cognitive and memory deterioration, progressive impairment of activities of daily living, and a variety of neuropsychiatric symptoms and behavioral disturbances (Jans et al., 2006) .
The majority of cases of AD are sporadic in nature, and the etiology of these cases remains unknown. Because evidence of genomic variation in association with late-onset Alzheimer's disease (LOAD) is increasingly emerging in both mutational and susceptibility loci, it is becoming clear that complex neurodegenerative processes underlie development and susceptibility to LOAD. More recently a large number of genes have been implicated as a risk to LOAD, but only a few of these associations have been replicated (Alonso Vilatela et al., 2012; Bettens et al., 2013) .
In patients with AD, the brain shows extracellular β-amyloid (Aβ) deposition as well as intracellular neurofibrillary tangles. Dystrophic neuritis, synaptic loss, and neuronal death are additional pathological hallmarks of AD. Inheritance of the ε4 allele of apolipoprotein E (APOE) is the strongest known genetic risk factor for AD. APOE is a polymorphic protein with 299 residues (Londono et al., 2012) . The three common isoforms ApoE2, E3, and E4 differ by only two amino acid residues at positions 112 and 158 (Londono et al., 2012 ). There are two major functional domains, the N-terminal domain (NT) which contains the major receptor binding region and the Cterminal domain (CT) which contains the lipid binding region and is also thought to bind amyloid beta (Tamamizu-Kato et al., 2008; Liu et al., 2011) .
Another interesting candidate gene is the low density lipoprotein receptor associated protein gene (LRPAP1). LRPAP1 is localized predominantly in endoplasmic reticulum (González et al., 2002) and has high affinity binding to lipoprotein receptor protein (LRP), which might function as a chaperone protein to nascent LRP during its intracellular transport (González et al., 2002) . In mice, a loss of function of RAP (RAP in mice, LRPAP in humans) leads to a reduced amount of mature LRP in the brain (González et al., 2002; Depboylu et al., 2006) . Thus, LRPAP1 may indirectly affect the formation of β -amyloid plaques.
Research into the role of metals in AD has rapidly advanced over the past two decades. Early studies described controversial links between trace metals and dementia. More recently, this concept has developed further with the understanding that a range of biometals and environmental metal toxins are likely to have a central role in determining the onset, progression, and clinical outcomes of AD and other forms of neurodegeneration. Subsequent studies on metals in AD have opened up vast areas of research including the role for metals in amyloid precursor protein (AβPP) metabolism and processing, Aβ cleavage and degradation, synaptic Aβ-metal interactions and neuroprotection associated with modulation of metal homeostasis.
The extensive international uses of organochlorine pesticides (OCPs) result in numerous acute intoxications. Evidence continues to accumulate that chronic pesticide exposure is associated with impaired health, including carcinogenesis, neurotoxicity, reproductive, development and immunological effects. The relationship of pesticide-related cytotoxicity to overt clinical organ disease is still unresolved.
The gene-environment interaction (GxE) approach is different from the direct individual approach of either genetic or environmental factors by postulating a causal role not only for either genes or environmental exposures in isolation, but for their synergistic participation in leading to disease i.e. AD, where the effect of one is imposing on the other. Keeping this in view the present study was undertaken to examine the interactive role of genetic and environmental factors in AD.
Material and methods

Study Population and Design.
This case-control study included total of 145 subjects, in which study group comprised of 70 patients diagnosed with AD and 75 healthy controls belonging to the state of Delhi and other surrounding states of North India, without any direct exposure of pesticides like occupational exposure etc. They were examined by neurologist in the out-patients Department of Neurology, Institute of Human Behaviour and Allied Science, Delhi, India. The sample size was calculated (α=0.05, β=0.20 and power=0.80) by using PS software, version 3.0.14. Patients 50 to 85 years old with complain of memory loss or other cognitive impairment were subjected to definition by the NINCDS-ADRDA criteria (McKhann et al., 1984) for AD and clinical diagnosis were supported by MRI/CT/PET brain scan. Additional inclusion criteria were a score of < 23 on the Mini-Mental State Examination (MMSE) and a Clinical Dementia Rating score of ≥ 0.5. Control group comprised of age and sex matched healthy volunteers. Approximately 10% randomly selected samples were repeated for quality control measures to prevent pre and post analytical error.
Subjects were excluded in both case and control groups if there was no consent for participation in the study, history of cerebral stroke, epilepsy, history of head trauma, and other concomitant disease potentially associated with dementia, chronic intake of drugs affecting cognitive processes, moderate to severe depressive episode and familial history of any kind of cognitive/behavioral abnormality. Nutritional deficiency, metabolic abnormalities and central nervous system infections were ruled out.
The study protocol and the Informed Consent Form (ICF) were reviewed and approved by Institutional Ethics Committee. Before any study specific procedures were performed, written consent was obtained from each subject.
APOE Genotyping.
Genomic DNA was isolated using peripheral blood by salting-out method (Miller et al., 1988) and the fourth exon of APOE gene was amplified, which encodes amino acid residues, 112 and 158. The specific primers 5'-ACAGAATTCGCCCCGGCCTGGTAC-AC-3' and 5'-TAAGCTTGGCACGGCTGTCC AAGGA-3' were used for amplification (Singh et al., 2012) . PCR assay was performed on Bio-Rad iQ5 cycler, USA, in a 20µl volume of 1x high-fidelity master mix (Bio-Rad) containing high-fidelity buffer, 0.04U/µl DNA polymerase, 1.5mM MgCl2, 200µM dNTPs. 7.5% dimethyl sulfoxide (DMSO), 10ng of genomic DNA, 0.5µM of each primer were used in final concentration. PCR profile consisted of a 1min hold at 98°C followed by 35 cycles of 98°C (30sec), 65°C (30 sec.) and 72°C (30sec) and final extention 72 0 C for 3min. The PCR product (244 bp) was digested by 10 units of Hha1. The digested product was run on 12 % polyacrylamide gel followed by the ethidium bromide staining. Allelic sizes were compared with known molecular weight marker.
LRPAP1 Genotyping.
Polymorphism in this gene arises due to 37-bp insertion in intron 5. The specific primers F 5'-GGTGTTTCTGGACACAAAGGA-3' and R 5'-AGTGTGCGTGGAGCCTATG-3' were used for amplification as described by Pandey et al. (2007) . PCR reaction containing1x high-fidelity buffer, 0.04U/µl DNA polymerase, 1.5mM MgCl2, 200µM dNTPs, 10ng of genomic DNA, 0.25µM of each primer in 20µl volume. PCR profile consisted of a 1min hold at 98 0 C followed by 35 cycles of 98°C (30sec), 64°C (30 sec.) and 72°C (30sec) and final extention 72°C for 3min.
Estimation of Organochlorine Pesticides.
Blood samples were collected using standard venepuncture techniques and stored at -80°C until analysis. The OCPs α-hexachlorocyclohexane (α-HCH), β-HCH, γ-HCH, Aldrin, Dieldrin, α-endosulfan, β-endosulfan, pp'-Dichlorodiphenyldichloroethylene (pp'-DDE), op'-DDE, pp'-Dichlorodiphenyl-trichloroethane (pp'-DDT), op '-DDT, pp'-Dichlorodiphenyldichloro-ethane (pp'-DDD) and op'-DDD were assayed. The compounds selected for assay were based on previous findings (Singh et al., 2012; Singh et al., 2013 ) that indicated the pesticides most commonly found in human samples and based on the compounds assayed by the Environmental Protection Agency. Samples were analysed on Perkin Elmer Gas Chromatograph equipped with 63Ni electron capture detector under standard operating procedure (Singh et al., 2012; Singh et al., 2013) .
OCPs were extracted from blood according to the method described by Bush et al. (1984) . Quantitative analysis of OCPs in each sample was analyzed by comparing the peak area with those obtained from a chromatogram of a mixed organochlorine standard (Supelco, Sigma-Aldrich) of known concentration. The detection limit of the detector was <0.05 pg per chloroethylene with nitrogen as a carrier gas. The detection limit of the method was 4pg/ml for each OCP. For quality control process, five blood samples in triplicate were spiked with a mixed standard of OCPs at 5 and 25ng/ml. The average recoveries of prepared samples exceeded 95%. The case and control samples were run in the same analytical batches and moreover, a quality check sample was always run with each set of samples for pesticide analysis to maintain accuracy.
Estimation of Serum Metals.
Magnesium (Mg), copper (Cu) and iron (Fe) were measured by commercial available kit manufactured by Fortress Diagnostics Ltd., UK by using an autoanalyser (Random Access Discrete Autoanalyser from Transasia).
Estimation of Serum Lipids.
Serum lipids i.e cholesterol, triglycerides, high density lipoprotein (HDL) and low density lipoprotein (LDL) were estimated by commercially available kit manufactured by Centronic GmbH, Germany by using an autoanalyser (Random Access Discrete Autoanalyser, XL-300 from Transasia).
Statistical Analysis.
All analyses were performed by using SPSS version 20.0 statistical software. Non parametric Mann Whitney test was used to compare variables with continuous data in cases and controls. P value less than 0.05 was taken as significant. R-values were derived from z values to calculate the effect size. Effect size was interpreted as under. Less than 0.3 r-value was taken as small effect size, r-value between 0.3-0.5 was taken as medium effect, large effect was r-value >0.5. χ2 tests were used to compare categorical data including presence of various alleles of APOE and LRPAP1 gene. Odds ratio and confidence interval of odds ratio were also calculated for parameters with significant odds ratio. After controlling for the effect of age, sex, smoking status, metals, pesticides and APOE alleles, effect of presence of APOE ε4 alleles was analysed on the disease status using logistic analysis.
Results
Figs 1 and 2 show different genotypes of APOE and LRPAP1 gene respectively. It is evident from table 1 that DD genotype in controls and DI genotype of LRPAP1 gene in AD were commonest followed by DI in controls and DD in cases. II genotype was rarest in control (n=1) and AD (n=6). Similarly, the ε3ε3 and ε3ε4 genotypes of APOE gene were commonest in controls and AD respectively. The ε4 allele of APOE gene were present in AD (n=44) and controls (n=11) with different combinations. The ε4 allele of APOE gene was present more frequently in AD as compared to controls. Chi square test proved that ε4 allele of APOE gene and I allele of LRPAP1 gene are statistically significant (χ2 = 33.875, p = 0.00, OR= 9.266, CI95%= 4.16, 20.6 and χ2 = 27.75, p = 0.000, OR = 0.144, CI95% = 0.068, 0.306 respectively). There was a significant difference in the levels of cholesterol, HDL, LDL, Mg, Cu, Fe, β-HCH, dieldrin and pp'-DDE in both the groups (Table 2 ). The inspection of median score revealed that while the levels of HDL and Mg were more in controls, but the levels of cholesterol, LDL, Fe, Cu and β-HCH were more in AD. The difference of medians of dieldrin and pp'-DDE could not be commented, as the medians were 0.00 in both the groups. The effect size of the difference was large for total cholesterol levels (r=0.58), medium for LDL (r=0.37), Mg (r=0.4), Cu (r=0.36) and dieldrin(r=0.48) levels, but for HDL (r=0.23) and pp'-DDE (r=0.22) it was small effect. After controlling of the confounding factors, the presence of I allele of LRPAP1 gene was still a predictor of the disease status (p = 0.014, OR = 15.046, 95% CI= 9.73, 55.55). This indicated that the presence of I allele of LRPAP gene increased the chances of being reported as a patient of AD by 15.046 times (Table 4) .
After controlling for the effect of the presence of ε4 allele of APOE and I allele of LRPAP1 gene, regression analysis showed ( Table 5 ) that out of the environmental factors studied, β-HCH levels were the best predictor of the presence of AD. Inspection of OR revealed that every one unit increase in the levels of β-HCH, chances of a person being reported with AD was 2.77 times (CI95% = 1.35, 5.69).
Discussion
In this study genetic polymorphism, metals and OCPs were examined to determine their relative contribution to AD as the notion of potential existence of GxE in AD has substantial impact on the interpretation whether there is any role of genetics and/or environmental contribution to this disorder.
The polymorphism of LRPAP1 gene was observed in both heterozygous and homozygous states (i.e., DI and II). The most crucial finding is positive association of LRPAP1 gene with AD. The effect of I allele of LRPAP1 gene appears to be independent of environmental factors and ε4 allele of APOE gene in AD, which is in accordance with Sanchez et al. (2001) and Schutte et al. (2003) . It is likely, that in the absence of ε4 allele of APOE gene, the LRPAP1 gene is a strong risk factor for AD (OR = 15.04). Previous studies have shown that overexpression of LRPAP1 leads to suppression of receptor-binding domain of LRP and LDLR (González et al., 2002; Depboylu et al., 2006) . As LRP helps in ligand binding and internalization of LRP ligands such as, apo-E-enriched LDL cholesterol and Aβ protein, it confers protection against LDL and Aβ -related toxicity. We studied the intronic polymorphism of LRPAP gene, the II, ID genotype and I allele which influences the production of protein and it could be contributory to AD through LRP-mediated mechanism.
The present study showed high frequency of ε4 allele in AD, which is in accordance with other findings (Thelma et al., 2001; Kapur et al., 2006; singh et al., 2012 ). The precise mechanisms by which APOE isoforms and lipids are involved in the pathogenesis of AD still remain unclear. Each APOE isoform has different lipoprotein binding affinity. The affinity of APOE for Aβ seems to be affected not only by isoform type but also by whether it is associated with lipids. Lipid associated APOE proteins have a higher Aβ binding affinity than the delipidated isoforms (Tokuda et al., 2000) . The APOE ε3 molecules that contained lipid associated particles (native state) had a two to threefold higher Aβ binding affinity than APOE ε4 (Tokuda et al., 2000) . Thus, the higher the lipid level, the more APOE/lipid complexes are formed, increasing the interaction with Aβ. Evans et al. (2004) suggested that AD progression was influenced by an APOE ε4-cholesterol interaction and that high cholesterol levels might increase APOE ε3 expression to a greater extent than APOE ε4, leading to increased Aβ deposition in individuals with APOE ε3 (Evans et al., 2004 ). The present study shows that the patients suffering from AD are 7.9 times more susceptible when having ε4 allele of APOE gene. This finding regarding the APOE ε4 allele frequency is in the corroboration with other studies of Indian origin (Thelma et al., 2001; Kapur et al., 2006) . Allele frequencies of the APOE polymorphism have been reported to vary among different population (Thelma et al., 2001; Kapur et al., 2006) . A possible explanation for this might be due to genetic drift in the population and/or sample size. The small sample size is a limitation of our study.
Apart from the genetic factors, we observed the association of environmental factors with the presence of AD and found that some metals and pesticide levels were significantly associated with AD as compared to controls. Among metals, when the effects of the presence of ε4 allele of APOE gene and I allele of LRPAP1 genes were controlled, the logistic regression analysis shows that the reduced levels of iron have been significantly associated with AD (OR = 0.806). It means the reduced levels of serum iron plays a protective role against AD, as its accumulation or abnormal interaction with cellular components such as proteins, lipids, or nucleic acids may also contribute to neurodegenerative disorders. The intracellular pool of free iron, the labile iron pool (LIP), has been well established to modulate the expression of various proteins, including the amyloid precursor protein (Frackowiak et al., 2009; Cho et al., 2010) . Coincidently, in previous studies, (Sullivan et al., 2009; Zhu et al., 2009 ) increased iron levels were found both in the cortex and cerebellum from the preclinical AD cases. Moreover, iron concentrations have been found to be increased in the bilateral hippocampus, parietal cortex, frontal white matter, putamen, caudate nucleus, thalamus, red nucleus, substantia nigra, and dentate nucleus subregions of patients with diagnosed AD and in normal elderly patients (Sullivan et al., 2009; Zhu et al., 2009) . It is important to note that these brain iron concentrations, particularly those in the parietal cortex at the early stages of AD, have been found to positively correlate with the severity of patient's cognitive impairment (Zhu et al., 2009) . Although extensive evidence links the deregulation of iron homeostasis and AD, relatively little is known about the resulting forms of iron that accumulate in the brain.
In this study when the effects of the presence of ε4 allele of APOE gene and I allele of LRPAP I genes were controlled, we found a significantly increased mean level of β-HCH and dieldrin in patients with AD as compared to controls. We found that every one unit increase in the levels of β-HCH and dieldrin increases the risk of AD by 2.77 and 2.34 times respectively. The association between OCP levels and neurodegenerative disease had been shown in many studies (Ray et al., 2000; Korrick and Sagiv 2008) . Richardson et al. (2009) showed that β-HCH levels were not associated with AD but this study was done on less sample size and in different cohort. It has also been in notices that although some OCPs are banned but still some are being used extensively throughout the world including India. The isomers of HCH (α-HCH, β-HCH and γ-HCH) can enter human body via food or drinking water, among them β-HCH is the most slowly excreted from the body. Dieldrin is a major metabolite of aldrin. Biodegradation of aldrin is generally slow and by hydrolytic process (mediated by the mixed-function mono-oxygenases) it is converted into dieldrin. Dieldrin is then metabolized at a much slower rate to hydrophilic metabolites thus retained in animal fats, plant waxes, and other similar organic matter in the environment. Experimental studies using mammalian system suggest that dieldrin induces oxidative stress and is nurotoxic (Kanthasamy et al., 2008) . These cellular responses are common during the progression and manifestation of AD. However, the dieldrin-mediated neurotoxicity mechanisms are still unclear.
Conclusion
The results of our study suggest that out of the environmental factors, increased β-HCH levels were the best predictor of presence of AD independent of the genetic component and the reduced levels of serum iron play a protective role against AD.
